Fundraising Fox

New Rhein Healthcare Investors, LLCFull Portfolio

13 tracked investments · listed companies and verified rows first

Alveus Therapeuticsalveustx.cominDec 2025

BiotechPhiladelphia, US

Raj Kannan(Executive Officer, Director)

BoardClaudio Nessi(Director)Jan Van de Bossche(Director)Garrett Ingram(Director)Gregory Parekh(Director)

Board seatIvan Gergel· per SEC Form D

Neuraptive TherapeuticsDec 2018SEC filinghigh confidence

BiotechLouisville, US

David Jackson(Executive Officer, Director)Gino DiSciullo(Director)Randy Hubbell(Director)

Board seatGreg ParekhIvan Gergel· per SEC Form D · $38.1M raise · filed Oct 2022

Alveus
American Injectables Inc.
Biocartis

Belgian oncology diagnostics company

Butterfly Medical

Israeli urology device company

Chase Pharmaceuticals

Irvine, CA based Alzheimer's drug company

Corsair Pharma
Neuraptive

Philadelphia based nerve repair drug company

Novagali Pharma

Paris, France based ophthalmology company

SAYVAA Pharma
Softhale

Belgian respiratory pharma company

Theranica

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.